TapewireFind a company

person · Reporting owner

SHAPIRO ALAN

Disclosed activity across 2 companies

Tapewire entity
112798
SEC CIK
0001241920

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DigitalOcean Holdings, Inc.DOCN · Entity 2625General CounselJune 01, 2023June 02, 2023
Everyday Health, Inc.EVDY · Entity 180558Exec VP & General CounselDecember 03, 2016December 06, 2016

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DigitalOcean Holdings, Inc.

Report date June 01, 2023 · Filed June 02, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect250,687 Reported balance After 2023-06-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-06-01 · Tax withholding · Disposed 4,800 · Balance 250,687

F1: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units and performance-based restricted stock units.

F2: The amount reported includes shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt from reporting pursuant to Rule 16a-3(f)(1)(i)(B).

Filing footnotes · ownership attribution and instrument terms

F1: The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units and performance-based restricted stock units.

F2: The amount reported includes shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt from reporting pursuant to Rule 16a-3(f)(1)(i)(B).

Everyday Health, Inc.

Report date December 03, 2016 · Filed December 06, 2016

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Ending reported balance After 2016-12-05 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2016-12-03 · Other · Disposed 5,370 · Balance 59,618

F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").

Row 2 · 2016-12-05 · Disposition to issuer · Disposed 59,618 · Balance 0

F2: Pursuant to the terms of the Reporting Person's employment agreement with the Issuer, the vesting of restricted stock units for an aggregate of 59,618 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding).

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").

F2: Pursuant to the terms of the Reporting Person's employment agreement with the Issuer, the vesting of restricted stock units for an aggregate of 59,618 shares was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 16, 2016 Filed Nov 17, 2016 11:07 UTC Everyday Health, Inc. EVDY · Entity 180558 SaleCommon Stock 30,000 $10.45 $313,500.00
Disclosure

SEC source: 0001415889-16-007451 · form4-11172016_081137.xml · nonDerivative · entry 5

SHAPIRO ALAN · CIK 0001241920 · EXEC VP, GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,988

Read SEC document
November 16, 2016 Filed Nov 17, 2016 11:07 UTC Everyday Health, Inc. EVDY · Entity 180558 Exercise / conversionCommon Stock 30,000 $7.68 $230,400.00
Disclosure

SEC source: 0001415889-16-007451 · form4-11172016_081137.xml · nonDerivative · entry 4

SHAPIRO ALAN · CIK 0001241920 · EXEC VP, GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2016 Filed Nov 17, 2016 11:07 UTC Everyday Health, Inc. EVDY · Entity 180558 SaleCommon Stock 66,666 $10.45 $696,659.70
Disclosure

SEC source: 0001415889-16-007451 · form4-11172016_081137.xml · nonDerivative · entry 3

SHAPIRO ALAN · CIK 0001241920 · EXEC VP, GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,988

Read SEC document
November 16, 2016 Filed Nov 17, 2016 11:07 UTC Everyday Health, Inc. EVDY · Entity 180558 Exercise / conversionCommon Stock 66,666 $9.27 $617,993.82
Disclosure

SEC source: 0001415889-16-007451 · form4-11172016_081137.xml · nonDerivative · entry 2

SHAPIRO ALAN · CIK 0001241920 · EXEC VP, GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 11:07 UTC Everyday Health, Inc. EVDY · Entity 180558 GrantCommon Stock 644 $5.17 $3,329.48
Disclosure

SEC source: 0001415889-16-007451 · form4-11172016_081137.xml · nonDerivative · entry 1

SHAPIRO ALAN · CIK 0001241920 · EXEC VP, GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,988

F1 · kind: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.